Canada markets closed

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed Price. Currency in KRW
Add to watchlist
117,200.00+1,500.00 (+1.30%)
As of 11:42AM KST. Market open.
Currency in KRW
Earnings EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts2276
Avg. Estimate6861,607.52,236.574,501
Low Estimate5671,0058343,652
High Estimate8052,2103,8405,221
Year Ago EPS1551,220-2,3332,236.57
Revenue EstimateCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts6688
Avg. Estimate454.77M491.09M1.75B1.86B
Low Estimate450.3M463M1.7B1.8B
High Estimate464.1M510.1M1.78B1.93B
Year Ago SalesN/AN/A1.63B1.75B
Sales Growth (year/est)N/AN/A7.70%6.50%
Earnings History2023-06-302023-09-302023-12-312024-03-31
EPS Est.1,343.962,425.93-433.5-197.5
EPS Actual1551,220-1,740-2,218
Difference-1,188.96-1,205.93-1,306.5-2,020.5
Surprise %-88.50%-49.70%-301.40%-1,023.00%
EPS TrendCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate6861,607.52,236.574,501
7 Days Ago6861,607.52,236.574,501
30 Days Ago6861,607.51,969.334,393.2
60 Days Ago884.51,4202,135.674,314.6
90 Days Ago884.51,4202,375.294,314.6
EPS RevisionsCurrent Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/A11
Up Last 30 DaysN/AN/A11
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth Estimates006280.KSIndustrySector(s)S&P 500
Current Qtr.342.60%N/AN/AN/A
Next Qtr.31.80%N/AN/AN/A
Current Year195.90%N/AN/AN/A
Next Year101.20%N/AN/AN/A
Next 5 Years (per annum)-10.67%N/AN/AN/A
Past 5 Years (per annum)-9.96%N/AN/AN/A